Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
42.32
+0.53 (1.27%)
At close: Aug 4, 2026, 4:00 PM EDT
42.33
+0.01 (0.02%)
After-hours: Aug 4, 2026, 7:22 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $5.62 billion as of August 4, 2026. Its market cap has increased by 774.78% in one year.
Market Cap
5.62B
Enterprise Value
5.33B
1-Year Change
774.78%
Ranking
Category
Stock Price
$42.32
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $5.62B, an increase of 843.57%. That is a compound annual growth rate of 41.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 5.62B | 325.89% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.46B |
| Erasca | 6.30B |
| CG Oncology | 6.28B |
| Belite Bio | 6.24B |
| Xenon Pharmaceuticals | 6.06B |
| Dianthus Therapeutics | 5.84B |
| Oruka Therapeutics | 5.82B |
| Ligand Pharmaceuticals | 5.70B |